This will play a video. - Onyx ONE Header


Resolute Onyx DES was shown to be safe and effective with superior acute performance in highly complex HBR patients with 1-month DAPT.1

Don’t miss an Onyx ONE update

Simply fill out the short form below to receive email updates as results become available.

* Indicates a required field.

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center


Windecker, et al. Data presented at TCT 2019; San Francisco, CA.